These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7738466)

  • 1. Effects of neuroleptic treatment on cortisol and 3-methoxy-4-hydroxyphenylethyl glycol levels in blood.
    Wik G
    J Endocrinol; 1995 Mar; 144(3):425-9. PubMed ID: 7738466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Energy metabolism in the hypothalamus and plasma cortisol levels in patients with schizophrenia.
    Wik G
    Horm Metab Res; 1996 Apr; 28(4):205-6. PubMed ID: 8740199
    [No Abstract]   [Full Text] [Related]  

  • 3. Blood biogenic amines during clozapine treatment of early-onset schizophrenia.
    Schulz E; Fleischhaker C; Clement HW; Remschmidt H
    J Neural Transm (Vienna); 1997; 104(10):1077-89. PubMed ID: 9503259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of treatment response in schizophrenia: clinical use of neuroleptic blood levels.
    Tang SW
    Can J Psychiatry; 1985 Jun; 30(4):249-50. PubMed ID: 2861888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of antipsychotic treatment on Insulin-like Growth Factor-1 and cortisol in schizophrenia: a longitudinal study.
    Venkatasubramanian G; Chittiprol S; Neelakantachar N; Shetty T; Gangadhar BN
    Schizophr Res; 2010 Jun; 119(1-3):131-7. PubMed ID: 20226630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexamethasone suppression test in schizophrenic patients before and during neuroleptic treatment.
    Wik G; Wiesel FA; Eneroth P; Sedvall G; Aström G
    Acta Psychiatr Scand; 1986 Aug; 74(2):161-7. PubMed ID: 2877544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sulpiride: a neuroleptic agent of new generation with unique pharmacological qualities and rather wide range of clinical applications].
    Pawłowski L
    Psychiatr Pol; 1993; 27(2):199-205. PubMed ID: 8104350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortisol and cytokines in chronic and treatment-resistant patients with schizophrenia: association with psychopathology and response to antipsychotics.
    Zhang XY; Zhou DF; Cao LY; Wu GY; Shen YC
    Neuropsychopharmacology; 2005 Aug; 30(8):1532-8. PubMed ID: 15886721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with risperidone for 4 weeks increased plasma 3-methoxy-4-hydroxypnenylglycol (MHPG) levels, but did not alter plasma brain-derived neurotrophic factor (BDNF) levels in schizophrenic patients.
    Yoshimura R; Hori H; Sugita A; Ueda N; Kakihara S; Umene W; Nakano Y; Shinkai K; Mitoma M; Ohta M; Shinkai T; Nakamura J
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1072-7. PubMed ID: 17459549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortisol/dehydroepiandrosterone ratio and responses to antipsychotic treatment in schizophrenia.
    Ritsner M; Gibel A; Maayan R; Ratner Y; Ram E; Biadsy H; Modai I; Weizman A
    Neuropsychopharmacology; 2005 Oct; 30(10):1913-22. PubMed ID: 15870835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-episode neuroleptic-free schizophrenics: concentrations of monoamines and their metabolites in plasma and their correlations with clinical responses to haloperidol treatment.
    Nagaoka S; Iwamoto N; Arai H
    Biol Psychiatry; 1997 Apr; 41(8):857-64. PubMed ID: 9099412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of cyclicity of the plasma dopamine metabolite, homovanillic acid, in neuroleptic treated schizophrenic patients.
    Davila R; Zumarraga M; Andia I; Friedhoff AJ
    Life Sci; 1989; 44(16):1117-21. PubMed ID: 2565009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of a unique new antipsychotic agent, sulpiride: effects on serum prolactin and growth hormone levels.
    Mielke DH; Gallant DM; Kessler C
    Am J Psychiatry; 1977 Dec; 134(12):1371-5. PubMed ID: 21571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroleptic drug effect on plasma dopamine-beta-hydroxylase in schizophrenia.
    Baron M; Gruen R; Levitt M; Kane J
    Neuropsychobiology; 1982; 8(6):312-4. PubMed ID: 6131392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association among serum cortisol, dehydroepiandrosterone-sulfate levels and psychiatric symptoms in men with chronic schizophrenia.
    Peng R; Li Y
    Compr Psychiatry; 2017 Jul; 76():113-118. PubMed ID: 28482249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. beta-Endorphin, cortisol, and prolactin in serum of schizophrenic patients during long-term neuroleptic treatment and after withdrawal: relationships to psychopathology.
    Naber D; Albus M; Muller F; Burke H; Welter D; Ackenheil M; Hippius H
    Psychopharmacol Bull; 1982 Oct; 18(4):224-6. PubMed ID: 6130563
    [No Abstract]   [Full Text] [Related]  

  • 17. Free-thyroxine index in schizophrenic patients before and after neuroleptic treatment.
    Rinieris P; Christodoulou GN; Souvatzoglou A; Koutras DA; Stefanis C
    Neuropsychobiology; 1980; 6(1):29-33. PubMed ID: 6102744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased plasma tryptophan and tryptophan/large neutral amino acid ratio in patients with neuroleptic-resistant schizophrenia: relationship to plasma cortisol concentration.
    Lee M; Jayathilake K; Dai J; Meltzer HY
    Psychiatry Res; 2011 Feb; 185(3):328-33. PubMed ID: 20699195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clozapine and risperidone influence on cortisol and estradiol levels in male patients with schizophrenia.
    Piriu G; Torac E; Gaman LE; Iosif L; Tivig IC; Delia C; Gilca M; Stoian I; Atanasiu V
    J Med Life; 2015; 8(4):548-51. PubMed ID: 26664488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of brain-derived neurotrophic factor and cortisol to sulfate of dehydroepiandrosterone molar ratio associated with clinical response to L-theanine as augmentation of antipsychotic therapy in schizophrenia and schizoaffective disorder patients.
    Miodownik C; Maayan R; Ratner Y; Lerner V; Pintov L; Mar M; Weizman A; Ritsner MS
    Clin Neuropharmacol; 2011; 34(4):155-60. PubMed ID: 21617527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.